Ethyl N~2~-benzoyl-L-argininate hydrochloride (1:1)(CAS: 2645-08-1)

Ethyl N-2-benzoyl-L-argininate hydrochloride (CAS: 2645-08-1) must comply with GHS classification for hazardous chemicals, REACH regulations, and FDA/EPA guidelines. Companies using or producing this compound must ensure it does not exceed permissible limits for specific toxic and hazardous characteristics, and must adhere to documentation and reporting requirements as outlined by these regulatory bodies.

Various alternatives can be used in the synthesis of Ethyl N-2-benzoyl-L-argininate hydrochloride (CAS: 2645-08-1), including other functionalized arginates or related compounds. Commonly, researchers may use ethyl N-benzoyl-L-argininate or ethyl N-2-phenylbenzoyl-L-argininate as substitutes, depending on the specific requirements and needs of the synthesis process.

The market for Ethyl N-2-benzoyl-L-argininate hydrochloride (CAS: 2645-08-1) is growing due to its applications in pharmaceuticals, particularly in the development of drugs targeting cardiovascular and neurodegenerative diseases. Research trends indicate an increasing focus on its potential in enzyme inhibition studies, which could lead to new drug discoveries and advancements in biotechnology.

Waste containing Ethyl N-2-benzoyl-L-argininate hydrochloride (CAS: 2645-08-1) should be collected in labeled containers and stored in a cool, well-ventilated area away from direct sunlight. Proper incineration or professional waste disposal services should be utilized, ensuring compliance with local hazardous waste regulations. Environmental protection measures include monitoring air and water quality to prevent contamination during disposal processes.